J. Hayward

发表

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

Julian Peto, Moyses Szklo, Anthony B. Miller, 1997, The Lancet.

Assessment of response to therapy in advanced breast cancer.

R. Rubens, P. Carbone, J. Hayward, 1977, British Journal of Cancer.

Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease

M. C. Leske, V. Beral, R. Collins, 2002, British Journal of Cancer.

Oestrogen receptors, clinical features and prognosis in stage III breast cancer.

R. Rubens, J. Hayward, R. King, 1982, European journal of cancer & clinical oncology.

Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer.

R. Rubens, J. Hayward, R. Millis, 1981, European journal of cancer.

The response to endocrine therapy in patients with advanced breast cancer in Great Britain and Japan.

R. Rubens, M. Yoshida, J. Hayward, 1982, European journal of cancer & clinical oncology.

Urinary epidermal growth factor excretion and breast cancer risk.

I. Fentiman, B. D. De Stavola, V. Fantl, 1988, European journal of cancer & clinical oncology.

Assessment of response to therapy in advanced breast cancer.

R. Rubens, P. Carbone, J. Hayward, 1977, British Journal of Cancer.

Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer.

R. K. Knight, R. Rubens, J. Hayward, 1982, European journal of cancer & clinical oncology.

Estrogen receptor status of advanced breast cancer immediately before chemotherapy does not predict for response

R. Rubens, J. Hayward, R. King, 2004, Cancer Chemotherapy and Pharmacology.

Sensory changes after treatment of operable breast cancer

I. Fentiman, J. Hayward, I. Karydas, 2005, Breast Cancer Research and Treatment.

Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792).

H. Bartelink, R. Sylvester, R. Rubens, 1989, European journal of cancer & clinical oncology.

Assessment of response to therapy in advanced breast cancer.

R. Rubens, P. Carbone, J. Hayward, 1977, British Journal of Cancer.